These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 9242377

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
    O-charoenrat P, Modjtahedi H, Rhys-Evans P, Court WJ, Box GM, Eccles SA.
    Cancer Res; 2000 Feb 15; 60(4):1121-8. PubMed ID: 10706134
    [Abstract] [Full Text] [Related]

  • 10. Differential function of STAT5 isoforms in head and neck cancer growth control.
    Leong PL, Xi S, Drenning SD, Dyer KF, Wentzel AL, Lerner EC, Smithgall TE, Grandis JR.
    Oncogene; 2002 Apr 25; 21(18):2846-53. PubMed ID: 11973644
    [Abstract] [Full Text] [Related]

  • 11. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
    Muller S, Su L, Tighiouart M, Saba N, Zhang H, Shin DM, Chen Z.
    Cancer; 2008 Jul 01; 113(1):97-107. PubMed ID: 18473353
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinoma.
    Thomas SM, Bhola NE, Zhang Q, Contrucci SC, Wentzel AL, Freilino ML, Gooding WE, Siegfried JM, Chan DC, Grandis JR.
    Cancer Res; 2006 Dec 15; 66(24):11831-9. PubMed ID: 17178880
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Growth stimulation of human head and neck squamous cell carcinoma cell lines by interleukin 4.
    Myers JN, Yasumura S, Suminami Y, Hirabayashi H, Lin Wc, Johnson JT, Lotze MT, Whiteside TL.
    Clin Cancer Res; 1996 Jan 15; 2(1):127-35. PubMed ID: 9816099
    [Abstract] [Full Text] [Related]

  • 19. Epidermal growth factor receptor directed therapy in head and neck cancer.
    Choong NW, Cohen EE.
    Crit Rev Oncol Hematol; 2006 Jan 15; 57(1):25-43. PubMed ID: 16207530
    [Abstract] [Full Text] [Related]

  • 20. Antitumor activity of anti-epidermal growth factor receptor monoclonal antibodies and cisplatin in ten human head and neck squamous cell carcinoma lines.
    Hoffmann T, Hafner D, Ballo H, Haas I, Bier H.
    Anticancer Res; 1997 Jan 15; 17(6D):4419-25. PubMed ID: 9494544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.